Market Closed -
Hong Kong S.E.
04:09:00 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
5.45
HKD
|
+1.87%
|
|
+2.64%
|
-16.79%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,768
|
5,228
|
8,745
|
6,391
|
7,625
|
6,467
|
-
|
-
|
Enterprise Value (EV)
1 |
6,281
|
3,283
|
6,489
|
3,816
|
4,961
|
5,967
|
4,144
|
4,568
|
P/E ratio
|
20.7
x
|
11
x
|
17.1
x
|
10.8
x
|
12.9
x
|
10.2
x
|
9.53
x
|
-
|
Yield
|
2.34%
|
3.92%
|
2.34%
|
3.21%
|
3.02%
|
3.37%
|
3.96%
|
-
|
Capitalization / Revenue
|
1.96
x
|
1.13
x
|
1.62
x
|
1.07
x
|
1.13
x
|
0.86
x
|
0.78
x
|
0.74
x
|
EV / Revenue
|
1.4
x
|
0.71
x
|
1.2
x
|
0.64
x
|
0.73
x
|
0.8
x
|
0.5
x
|
0.52
x
|
EV / EBITDA
|
6.22
x
|
2.9
x
|
5.19
x
|
2.76
x
|
3.56
x
|
4.13
x
|
2.69
x
|
3.19
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.59
x
|
0.91
x
|
1.46
x
|
0.99
x
|
1.11
x
|
0.86
x
|
0.79
x
|
0.73
x
|
Nbr of stocks (in thousands)
|
1,280,784
|
1,280,784
|
1,280,784
|
1,280,784
|
1,280,784
|
1,280,784
|
-
|
-
|
Reference price
2 |
6.846
|
4.082
|
6.828
|
4.990
|
5.953
|
5.049
|
5.049
|
5.049
|
Announcement Date
|
3/30/20
|
3/28/21
|
3/18/22
|
3/22/23
|
3/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,476
|
4,607
|
5,400
|
5,992
|
6,773
|
7,497
|
8,248
|
8,744
|
EBITDA
1 |
1,011
|
1,132
|
1,251
|
1,380
|
1,393
|
1,445
|
1,542
|
1,432
|
EBIT
1 |
918.1
|
943.5
|
1,080
|
1,213
|
1,116
|
1,272
|
1,346
|
1,268
|
Operating Margin
|
20.51%
|
20.48%
|
19.99%
|
20.25%
|
16.48%
|
16.97%
|
16.32%
|
14.5%
|
Earnings before Tax (EBT)
1 |
923.5
|
939.6
|
1,045
|
1,212
|
1,162
|
1,290
|
1,376
|
1,314
|
Net income
1 |
417.6
|
467.6
|
507.2
|
582.9
|
590.2
|
631.4
|
673.9
|
659.9
|
Net margin
|
9.33%
|
10.15%
|
9.39%
|
9.73%
|
8.71%
|
8.42%
|
8.17%
|
7.55%
|
EPS
2 |
0.3300
|
0.3700
|
0.4000
|
0.4600
|
0.4600
|
0.4950
|
0.5300
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1600
|
0.1600
|
0.1600
|
0.1600
|
0.1800
|
0.1700
|
0.2000
|
-
|
Announcement Date
|
3/30/20
|
3/28/21
|
3/18/22
|
3/22/23
|
3/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,486
|
1,946
|
2,256
|
2,575
|
2,664
|
499
|
2,322
|
1,898
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
7.7%
|
8.31%
|
8.66%
|
9.35%
|
8.83%
|
8.77%
|
8.62%
|
7.79%
|
ROA (Net income/ Total Assets)
|
4.13%
|
4.37%
|
4.5%
|
4.84%
|
-
|
4.6%
|
4.7%
|
-
|
Assets
1 |
10,120
|
10,705
|
11,267
|
12,039
|
-
|
13,726
|
14,337
|
-
|
Book Value Per Share
2 |
4.320
|
4.480
|
4.670
|
5.060
|
5.380
|
5.870
|
6.390
|
6.870
|
Cash Flow per Share
2 |
0.8200
|
0.3400
|
0.8100
|
0.5700
|
-
|
1.690
|
0.8700
|
-
|
Capex
1 |
276
|
546
|
169
|
172
|
-
|
422
|
463
|
-
|
Capex / Sales
|
6.16%
|
11.85%
|
3.12%
|
2.88%
|
-
|
5.63%
|
5.61%
|
-
|
Announcement Date
|
3/30/20
|
3/28/21
|
3/18/22
|
3/22/23
|
3/22/24
|
-
|
-
|
-
|
Last Close Price
5.049
CNY Average target price
6.058
CNY Spread / Average Target +19.97% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.79% | 894M | | +39.33% | 6.11B | | -18.38% | 4.35B | | -9.17% | 3.19B | | +3.98% | 3.15B | | -3.41% | 2.51B | | +48.74% | 1.98B | | -4.82% | 1.74B | | -1.24% | 1.63B | | -8.96% | 1.6B |
Alternative Medicine
|